Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non‐small‐cell lung cancer cell line (H460) and one normal pr...
Saved in:
Published in | Chembiochem : a European journal of chemical biology Vol. 23; no. 18; pp. e202200259 - n/a |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Wiley Subscription Services, Inc
16.09.2022
Wiley-VCH Verlag |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non‐small‐cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18‐electron complexes were designed with four water‐soluble phosphine ligands to increase the water‐solubility character of the corresponding electron‐deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine‐3,3′,3′′‐trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16‐electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay.
Phosphine ligands are coordinated to [(η6‐p‐cymene)Ru(maleonitriledithiolate)] to obtain ruthenium(II) complexes with different hydrophilicities. Characterisation and evaluation of the in vitro cytotoxicity towards two ovarian, one non‐small‐cell lung cancer cell lines and one normal prostate cell line are presented. A mechanism of action based on reactive oxygen species production leading to apoptosis is suggested. In vivo evaluation suggests some evidence of tumour growth delay. |
---|---|
AbstractList | The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate-based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non-small-cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18-electron complexes were designed with four water-soluble phosphine ligands to increase the water-solubility character of the corresponding electron-deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine-3,3',3''-trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16-electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay.The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate-based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non-small-cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18-electron complexes were designed with four water-soluble phosphine ligands to increase the water-solubility character of the corresponding electron-deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine-3,3',3''-trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16-electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay. The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non‐small‐cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18‐electron complexes were designed with four water‐soluble phosphine ligands to increase the water‐solubility character of the corresponding electron‐deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine‐3,3′,3′′‐trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16‐electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay. The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non‐small‐cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18‐electron complexes were designed with four water‐soluble phosphine ligands to increase the water‐solubility character of the corresponding electron‐deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine‐3,3′,3′′‐trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16‐electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay. Phosphine ligands are coordinated to [(η6‐p‐cymene)Ru(maleonitriledithiolate)] to obtain ruthenium(II) complexes with different hydrophilicities. Characterisation and evaluation of the in vitro cytotoxicity towards two ovarian, one non‐small‐cell lung cancer cell lines and one normal prostate cell line are presented. A mechanism of action based on reactive oxygen species production leading to apoptosis is suggested. In vivo evaluation suggests some evidence of tumour growth delay. The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non‐small‐cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18‐electron complexes were designed with four water‐soluble phosphine ligands to increase the water‐solubility character of the corresponding electron‐deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine‐3,3′,3′′‐trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16‐electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay. |
Author | Azmanova, Maria Seaton, Colin C. Shnyder, Steven D. Pitto‐Barry, Anaïs Cooper, Patricia A. Rafols, Laia |
Author_xml | – sequence: 1 givenname: Maria orcidid: 0000-0002-6800-3772 surname: Azmanova fullname: Azmanova, Maria organization: University of Bradford – sequence: 2 givenname: Laia orcidid: 0000-0002-2159-9636 surname: Rafols fullname: Rafols, Laia organization: University of Bradford – sequence: 3 givenname: Patricia A. orcidid: 0000-0002-6875-0313 surname: Cooper fullname: Cooper, Patricia A. organization: University of Bradford – sequence: 4 givenname: Colin C. surname: Seaton fullname: Seaton, Colin C. organization: University of Bradford – sequence: 5 givenname: Steven D. orcidid: 0000-0002-4647-2340 surname: Shnyder fullname: Shnyder, Steven D. organization: University of Bradford – sequence: 6 givenname: Anaïs orcidid: 0000-0001-5100-0922 surname: Pitto‐Barry fullname: Pitto‐Barry, Anaïs email: anais.pitto-barry@universite-paris-saclay.fr organization: University of Bradford |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35838006$$D View this record in MEDLINE/PubMed https://cnrs.hal.science/hal-03752249$$DView record in HAL |
BookMark | eNqFkc1uEzEUhS1URH9gyxKNxAYWCf6ZGcfswqjQSpGKVBASG8v2XFNXHjvYM4XseASekSfBIWmRKiFWtq-_c659zzE6CDEAQk8JnhOM6SujnZlTTGk5NOIBOiI1EzPeMnaw39eU8kN0nPM1xli0jDxCh6xZsAXG7RH6vAyjMyoYSNUnNUL69ePnZfST9lBdpC8qxDSNVxDcNFRdHNYevkN-XV1uQqlmlysV-up9AuNdKD6-Or1RflKji-ExemiVz_Bkv56gj29PP3Rns9XFu_NuuZqZuuZipqnFlLc9MFUe1Qi9MEJYQSz0tilXxHLCCG3awvBCad3qheVWgwCtes1O0Mud75Xycp3coNJGRuXk2XIltzXMeENpLW5IYV_s2HWKXyfIoxxcNuC9ChCnLGkrCG64EKygz--h13FKofxEUk7qpm1Iywv1bE9NeoD-rv_thAtQ7wCTYs4JrDRu_DOfMSnnJcFyG6TcBinvgiyy-T3ZrfM_BWIn-OY8bP5Dy-7NefdX-xtMRbDs |
CitedBy_id | crossref_primary_10_1002_cplu_202400621 crossref_primary_10_1039_D4MD00306C crossref_primary_10_1002_hlca_202300064 |
Cites_doi | 10.1016/j.poly.2019.02.041 10.1021/ar9502341 10.1039/C9CC01974J 10.3390/M1025 10.1246/cl.190179 10.1002/ejic.200700112 10.1002/cmdc.201900528 10.1021/acsami.8b01776 10.1039/C6DT00668J 10.1039/D0SC00897D 10.1039/C8MT00072G 10.1021/acsomega.8b02154 10.1155/2015/673512 10.1021/acs.jmedchem.8b00958 10.1016/S0022-328X(00)00345-4 10.1002/chem.200901939 10.1038/s41416-020-0926-3 10.1002/anie.201912219 10.1002/cbic.201900236 10.1016/j.inoche.2007.07.023 10.1080/10426509008045879 10.1039/C7DT02827J 10.1021/jacs.1c13137 10.3390/molecules26051390 10.1002/cmdc.202000096 10.1021/om2012425 10.1016/j.ejmech.2019.112030 10.1002/cmdc.202000672 10.1021/om900483t 10.1016/j.ccr.2021.213950 10.1039/C5DT04398K 10.3390/molecules25194540 10.1016/j.jorganchem.2010.11.009 10.1016/j.molcata.2003.01.001 10.1039/C8DT01232F 10.1002/ejic.201501458 10.1002/ange.201912219 |
ContentType | Journal Article |
Copyright | 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH. 2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Attribution |
Copyright_xml | – notice: 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH – notice: 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH. – notice: 2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Attribution |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7QO 7TM 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 1XC VOOES |
DOI | 10.1002/cbic.202200259 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Biotechnology Research Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef Virology and AIDS Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1439-7633 |
EndPage | n/a |
ExternalDocumentID | oai_HAL_hal_03752249v1 35838006 10_1002_cbic_202200259 CBIC202200259 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Royal Society funderid: URF150295; RGF\EA\201001 – fundername: Academy of Medical Sciences/the Wellcome Trust/the Government Department of Business, Energy and Industrial/the British Heart Foundation Springboard Award funderid: SBF003\1170 – fundername: Wellcome Trust – fundername: British Heart Foundation grantid: SBF003\1170 |
GroupedDBID | --- -DZ -~X 05W 0R~ 1L6 1OC 24P 29B 33P 3WU 4.4 4ZD 50Y 5GY 5VS 66C 6J9 6P2 77Q 8-0 8-1 8UM A00 AAESR AAHHS AAHQN AAIHA AAMNL AANLZ AAXRX AAYCA AAZKR ABCUV ABIJN ABJNI ABLJU ACAHQ ACCFJ ACCZN ACGFS ACIWK ACPOU ACPRK ACXBN ACXQS ADBBV ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFRAH AFWVQ AFZJQ AHBTC AHMBA AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMYDB AZVAB BDRZF BFHJK BMXJE BRXPI CS3 DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EMOBN F5P G-S GNP HBH HGLYW HHY HHZ HZ~ IH2 IX1 JPC KQQ LATKE LAW LEEKS LITHE LOXES LUTES LYRES MEWTI MXFUL MXSTM MY~ NNB O9- OIG P2P P2W P4E PQQKQ R.K ROL RWI RX1 SUPJJ SV3 V2E W99 WBKPD WH7 WJL WOHZO WXSBR WYJ XPP XV2 Y6R YZZ ZZTAW ~KM ~S- AAYXX AEYWJ AGHNM AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QL 7QO 7TM 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 .GJ 1XC 31~ 53G AANHP AASGY ACBWZ ACRPL ACYXJ ADNMO AFFNX AGQPQ AI. ASPBG AVWKF AZFZN EJD FEDTE GODZA HVGLF VH1 VOOES XSW ZGI |
ID | FETCH-LOGICAL-c4479-b2f0276de3a83859b8c99f91fedf5f021f713125676d7de3bb6b8f7fbe9ebadb3 |
IEDL.DBID | DR2 |
ISSN | 1439-4227 1439-7633 |
IngestDate | Fri May 09 12:20:24 EDT 2025 Fri Jul 11 10:15:24 EDT 2025 Fri Jul 25 12:10:03 EDT 2025 Mon Jul 21 05:57:35 EDT 2025 Tue Jul 01 04:35:22 EDT 2025 Thu Apr 24 23:03:26 EDT 2025 Wed Jan 22 16:23:53 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 18 |
Keywords | in vivo evaluation half-sandwich complexes metallodrugs phosphine ligands bioinorganic chemistry phosphines ligands antineoplastic agents drug screening assays in vivo evaluation lung neoplasms antitumor water organophosphorus compounds ovarian neoplasms ruthenium carcinoma tumor reactive oxygen species non-small-cell lung female coordination complexes humans cell line |
Language | English |
License | Attribution 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH. Attribution: http://creativecommons.org/licenses/by |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4479-b2f0276de3a83859b8c99f91fedf5f021f713125676d7de3bb6b8f7fbe9ebadb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-2159-9636 0000-0002-6875-0313 0000-0002-6800-3772 0000-0001-5100-0922 0000-0002-4647-2340 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcbic.202200259 |
PMID | 35838006 |
PQID | 2714565167 |
PQPubID | 986344 |
PageCount | 10 |
ParticipantIDs | hal_primary_oai_HAL_hal_03752249v1 proquest_miscellaneous_2691057993 proquest_journals_2714565167 pubmed_primary_35838006 crossref_citationtrail_10_1002_cbic_202200259 crossref_primary_10_1002_cbic_202200259 wiley_primary_10_1002_cbic_202200259_CBIC202200259 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 16, 2022 |
PublicationDateYYYYMMDD | 2022-09-16 |
PublicationDate_xml | – month: 09 year: 2022 text: September 16, 2022 day: 16 |
PublicationDecade | 2020 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Weinheim |
PublicationTitle | Chembiochem : a European journal of chemical biology |
PublicationTitleAlternate | Chembiochem |
PublicationYear | 2022 |
Publisher | Wiley Subscription Services, Inc Wiley-VCH Verlag |
Publisher_xml | – name: Wiley Subscription Services, Inc – name: Wiley-VCH Verlag |
References | 2021; 26 2011; 696 2019; 55 2019; 2 2021; 445 2017; 46 2019; 14 2020; 15 2007 2020; 188 2020; 123 2020; 11 2018; 61 2007; 10 2012; 31 2019 2019; 58 131 2018; 47 2009; 28 2022; 144 2000; 607 2021; 16 2018; 3 2018; 2018 2004; 215 2019; 20 1990; 48 1997; 30 2019; 48 2015; 2015 2020; 25 2016 2018; 10 2019; 172 2009; 15 2016; 45 e_1_2_10_23_1 e_1_2_10_45_2 e_1_2_10_46_1 e_1_2_10_24_1 e_1_2_10_44_2 e_1_2_10_20_2 e_1_2_10_20_3 e_1_2_10_21_2 e_1_2_10_22_1 e_1_2_10_43_1 e_1_2_10_42_1 e_1_2_10_41_1 e_1_2_10_1_1 e_1_2_10_2_1 e_1_2_10_3_2 e_1_2_10_17_2 e_1_2_10_18_2 e_1_2_10_19_1 e_1_2_10_39_2 e_1_2_10_16_1 e_1_2_10_38_2 Wang X. (e_1_2_10_40_1) 2019; 2 e_1_2_10_4_2 e_1_2_10_5_1 e_1_2_10_7_2 e_1_2_10_13_2 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_6_2 e_1_2_10_15_1 e_1_2_10_36_1 e_1_2_10_9_2 e_1_2_10_35_1 e_1_2_10_8_2 e_1_2_10_12_2 e_1_2_10_34_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_31_1 e_1_2_10_30_1 e_1_2_10_28_2 e_1_2_10_29_1 e_1_2_10_27_2 e_1_2_10_25_1 e_1_2_10_26_1 |
References_xml | – volume: 607 start-page: 203 year: 2000 end-page: 207 publication-title: J. Organomet. Chem. – volume: 58 131 start-page: 18482 18653 year: 2019 2019 end-page: 18486 18657 publication-title: Angew. Chem. Int. Ed. Angew. Chem. – volume: 696 start-page: 989 year: 2011 end-page: 998 publication-title: J. Organomet. Chem. – volume: 172 start-page: 22 year: 2019 end-page: 27 publication-title: Polyhedron – volume: 3 start-page: 15623 year: 2018 end-page: 15627 publication-title: ACS Omega – start-page: 2926 year: 2007 end-page: 2933 publication-title: Eur. J. Inorg. Chem. – volume: 10 start-page: 696 year: 2018 end-page: 712 publication-title: Metallomics – volume: 31 start-page: 756 year: 2012 end-page: 767 publication-title: Organometallics – volume: 144 start-page: 4091 year: 2022 end-page: 4101 publication-title: J. Am. Chem. Soc. – volume: 10 start-page: 13693 year: 2018 end-page: 13701 publication-title: ACS Appl. Mater. Interfaces – volume: 25 start-page: 4540 year: 2020 publication-title: Molecules – start-page: 1267 year: 2016 end-page: 1273 publication-title: Eur. J. Inorg. Chem. – volume: 10 start-page: 1222 year: 2007 end-page: 1225 publication-title: Inorg. Chem. Commun. – volume: 215 start-page: 23 year: 2004 end-page: 32 publication-title: J. Mol. Catal. A – volume: 16 start-page: 624 year: 2021 end-page: 629 publication-title: ChemMedChem – volume: 48 start-page: 37 year: 1990 end-page: 40 publication-title: Phosphor. Sulfur Silicon Related Elements – volume: 48 start-page: 916 year: 2019 end-page: 924 publication-title: Chem. Lett. – volume: 61 start-page: 9246 year: 2018 end-page: 9255 publication-title: J. Med. Chem. – volume: 20 start-page: 2876 year: 2019 end-page: 2882 publication-title: ChemBioChem – volume: 28 start-page: 4249 year: 2009 end-page: 4251 publication-title: Organometallics – volume: 26 start-page: 1390 year: 2021 publication-title: Molecules – volume: 445 year: 2021 publication-title: Coord. Chem. Rev. – volume: 14 start-page: 1887 year: 2019 end-page: 1893 publication-title: ChemMedChem – volume: 46 start-page: 15676 year: 2017 end-page: 15683 publication-title: Dalton Trans. – volume: 55 start-page: 6038 year: 2019 end-page: 6041 publication-title: Chem. Commun. – volume: 2 start-page: 141 year: 2019 end-page: 160 publication-title: Cancer Drug Resistance – volume: 15 start-page: 982 year: 2020 end-page: 987 publication-title: ChemMedChem – volume: 47 start-page: 7290 year: 2018 end-page: 7299 publication-title: Dalton Trans. – volume: 45 start-page: 1763 year: 2016 end-page: 1768 publication-title: Dalton Trans. – volume: 123 start-page: 871 year: 2020 end-page: 873 publication-title: Br. J. Cancer – volume: 2018 start-page: M1025 year: 2018 publication-title: Molbank – volume: 45 start-page: 11791 year: 2016 end-page: 11800 publication-title: Dalton Trans. – volume: 11 start-page: 5466 year: 2020 end-page: 5480 publication-title: Chem. Sci. – volume: 15 start-page: 12283 year: 2009 end-page: 12291 publication-title: Chem. Eur. J. – volume: 2015 year: 2015 publication-title: BioMed Res. Int. – volume: 30 start-page: 97 year: 1997 end-page: 102 publication-title: Acc. Chem. Res. – volume: 188 year: 2020 publication-title: Eur. J. Med. Chem. – ident: e_1_2_10_8_2 doi: 10.1016/j.poly.2019.02.041 – ident: e_1_2_10_12_2 doi: 10.1021/ar9502341 – ident: e_1_2_10_21_2 doi: 10.1039/C9CC01974J – ident: e_1_2_10_28_2 doi: 10.3390/M1025 – ident: e_1_2_10_5_1 – ident: e_1_2_10_9_2 doi: 10.1246/cl.190179 – ident: e_1_2_10_2_1 – ident: e_1_2_10_32_1 doi: 10.1002/ejic.200700112 – ident: e_1_2_10_22_1 doi: 10.1002/cmdc.201900528 – ident: e_1_2_10_17_2 doi: 10.1021/acsami.8b01776 – ident: e_1_2_10_36_1 doi: 10.1039/C6DT00668J – ident: e_1_2_10_6_2 doi: 10.1039/D0SC00897D – ident: e_1_2_10_3_2 doi: 10.1039/C8MT00072G – ident: e_1_2_10_18_2 doi: 10.1021/acsomega.8b02154 – ident: e_1_2_10_42_1 doi: 10.1155/2015/673512 – ident: e_1_2_10_43_1 – ident: e_1_2_10_45_2 doi: 10.1021/acs.jmedchem.8b00958 – ident: e_1_2_10_10_1 doi: 10.1016/S0022-328X(00)00345-4 – ident: e_1_2_10_39_2 doi: 10.1002/chem.200901939 – ident: e_1_2_10_16_1 – ident: e_1_2_10_19_1 – ident: e_1_2_10_4_2 doi: 10.1038/s41416-020-0926-3 – ident: e_1_2_10_20_2 doi: 10.1002/anie.201912219 – ident: e_1_2_10_26_1 – ident: e_1_2_10_7_2 doi: 10.1002/cbic.201900236 – ident: e_1_2_10_25_1 doi: 10.1016/j.inoche.2007.07.023 – ident: e_1_2_10_31_1 doi: 10.1080/10426509008045879 – ident: e_1_2_10_15_1 doi: 10.1039/C7DT02827J – ident: e_1_2_10_37_1 – ident: e_1_2_10_46_1 doi: 10.1021/jacs.1c13137 – ident: e_1_2_10_30_1 doi: 10.3390/molecules26051390 – volume: 2 start-page: 141 year: 2019 ident: e_1_2_10_40_1 publication-title: Cancer Drug Resistance – ident: e_1_2_10_23_1 doi: 10.1002/cmdc.202000096 – ident: e_1_2_10_1_1 – ident: e_1_2_10_13_2 doi: 10.1021/om2012425 – ident: e_1_2_10_44_2 doi: 10.1016/j.ejmech.2019.112030 – ident: e_1_2_10_24_1 doi: 10.1002/cmdc.202000672 – ident: e_1_2_10_38_2 doi: 10.1021/om900483t – ident: e_1_2_10_41_1 doi: 10.1016/j.ccr.2021.213950 – ident: e_1_2_10_14_1 doi: 10.1039/C5DT04398K – ident: e_1_2_10_27_2 doi: 10.3390/molecules25194540 – ident: e_1_2_10_35_1 doi: 10.1016/j.jorganchem.2010.11.009 – ident: e_1_2_10_33_1 doi: 10.1016/j.molcata.2003.01.001 – ident: e_1_2_10_29_1 doi: 10.1039/C8DT01232F – ident: e_1_2_10_34_1 doi: 10.1002/ejic.201501458 – ident: e_1_2_10_11_1 – ident: e_1_2_10_20_3 doi: 10.1002/ange.201912219 |
SSID | ssj0009631 |
Score | 2.3876262 |
Snippet | The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various... The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various... The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate-based ruthenium metal complexes bearing various... The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate-based ruthenium metal complexes bearing various... |
SourceID | hal proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e202200259 |
SubjectTerms | Antineoplastic Agents - pharmacology Apoptosis Biocompatibility bioinorganic chemistry Cancer Carcinoma, Non-Small-Cell Lung Cell Line, Tumor Chemical Sciences Coordination Complexes - toxicity Coordination compounds Cytotoxicity Drug Screening Assays, Antitumor Female half-sandwich complexes Humans In vivo methods and tests in vivo evaluation Life Sciences Ligands Lung cancer Lung Neoplasms Medicinal Chemistry Metal complexes metallodrugs Organophosphorus Compounds Organoruthenium complexes Ovarian cancer Ovarian Neoplasms Phosphine phosphine ligands Phosphines Prostate Prostate cancer Reactive Oxygen Species Ruthenium Ruthenium - pharmacology Ruthenium compounds Synthesis Toxicity Tumor cell lines Tumors Water Xenografts Xenotransplantation |
Title | Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcbic.202200259 https://www.ncbi.nlm.nih.gov/pubmed/35838006 https://www.proquest.com/docview/2714565167 https://www.proquest.com/docview/2691057993 https://cnrs.hal.science/hal-03752249 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RXuBCoeWRUiqDEJzSNo7zcG_LqtWCAFVARcUlshNbrLr1VptdRDnxE_ob-SXMOI-yIIQEtzzGipOMx9-Mx98APCkrXhmTJKFI0ASK3MSh4taGBqdKbJFL4wP6r9-ko2Px8iQ5-WkXf8MP0QfcaGR4e00DXOl694o0tNRjoiDklGWQ0A4-StgiVPT2ij8Ktct7XIKWOznPOtbGPb673HxpVlr5RDmRvwPOZfzqJ6DDNVBd15u8k9OdxVzvlF9_YXX8n3e7BTdbdMoGjTrdhmvGrcPGwKFnfnbBnjKfL-oD8etwfdjVituAjwNHMXFUoBn7gOh19v3bJQXc9MQwv9tzOqNMejdenDGyQBPzxdT77N2Fw6v1uGbKVewIjW-7T5Md9CTkd-D48OD9cBS2VRvCUohMhppbdHXTysQqj_NE6ryU0srImsomeCuy6BcjrEpRJkMprVOd28xqI41WlY7vwqqbOnMfWJRYq6o0RUhRiTxWWnGZl-iQJnsqEyYOIOz-WlG2lOZUWWNSNGTMvKAPWfQfMoBnvfx5Q-bxR8nHqAS9EHFwjwavCrpGRYMR98jPUQBbnY4U7civC55FBJKjNAvgUX8bfwctxChnpguUSSWVV0ZoGMC9Rrf6R8W0jo2mMADuNeQvHS2Gz18M-7PNf2n0AG7QMSXBROkWrM5nC_MQkdZcb8MKF0fbfkz9AKhJIJI |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LTxRBEK4AHvCCCiojqK3xcRpgep5t4mFdILuyEKMQiZexe6Y7blxmyc6uup78Cf4V_wo_gV9i1bzIaoyJCQeP01Pz7Hp39VcAj5KUp1r7vu35qAK9SLu25MbYGk0lXhEJXST09w-CzpH38tg_noMf9V6YEh-iSbiRZBT6mgScEtKbF6ihieoTBiGnMgNfVHWVe3r6GaO2_Hl3G6f4Mee7O4ftjl01FrATzwuFrbjBaCxItSsjN_KFihIhjHCMTo2PpxyDoRta_gBpQqRSKlCRCY3SQiuZKhfvOw9XqI04wfVvv75ArEJ-LmI8jxZYOQ9rnMgtvjn7vjN2cP4DVWH-7uLOesyFydu9Bmf1zyorXT5uTMZqI_n6C47kf_U3r8NS5YCzVikxN2BOZ8uw0srkeHgyZU9YURJbrDUsw2K7boe3Au9aGaX9UUZG7C066KPzb98pp6gGmhUbWocj2iyQ9ScnjJTsQH_R-TP2ZprhaN7PmcxS9grtS7UVle00OOs34ehSvvgWLGTDTK8Cc3xjZBoE6DWlXuRKJbmIEoy5_S0Zetq1wK7ZJE4q1HZqHjKIS7xpHtPExc3EWfC0oT8t8Ur-SPkQua4hIpjxTqsX0xj1RUbXTnxyLFivmTKulFse89ChOMAJQgseNKdxOmitSWZ6OEGaQFAHafR-LbhdMnPzKJeW6lHbW8ALlvzLi8btF912c3TnXy66D4udw_1e3Ose7K3BVRqnmh8nWIeF8Wii76JjOVb3ClFm8P6yuf0nOCWANA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB61RQIuCFp-UgoYxM8pauMkTozEYdl2tUtLtRJUVL2YOLHVlbbZatNt2RuP0EfpM_EkzOSvWiGEhNRjnEliZezxN-PxNwCv04xnxoShG4RoAoPY-G7CrXUNLpX4RCxNGdD_vC_6B8Gnw_BwCa6aszAVP0QbcKOZUdprmuCnmd28Jg1N9YgoCDllGYSyTqvcNfMLdNqKD4Nt1PAbzns7X7t9t64r4KZBEElXc4vOmMiMn8R-HEodp1Ja6VmT2RBveRY9N1z4BcpEKKW10LGNrDbS6CTTPr53GW7RDiMlkfFgeE3zK8oKiAhCpBtwHjU0kVt8c7G_C8vg8jElYf6JcBcBc7ni9e7DvRqqsk41th7AkslXYa2To5t-MmdvWZk8WkblV-FOtykctwZHnZwC5DiapuwbQtnpr5-XFH3TY8PKo5-TKaXV56PZCSNzNDY_TPGefZnn2FqMCpbkGRuiJa4PbbKdlpH8IRzcyK9-BCv5JDdPgHmhtUkmBOKLLIj9RCdcxil6p-FWEgXGd8Bt_qhKa35zKrMxVhUzM1ekAdVqwIF3rfxpxezxV8lXqKBWiAi5-509RW1UQRhBkDz3HNho9KdqM1AoHnmEmD0ROfCyvY3qoF2ZJDeTGcoISbWWESc68LjSe_spnza10S46wMuB8I-Oqu7HQbe9Wv-fh17A7eF2T-0N9nefwl1qpuQYT2zAytl0Zp4hAjvTz8tBz-D7Tc-y30hAPLk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anticancer+Water%E2%80%90Soluble+Organoruthenium+Complexes%3A+Synthesis+and+Preclinical+Evaluation&rft.jtitle=Chembiochem+%3A+a+European+journal+of+chemical+biology&rft.au=Azmanova%2C+Maria&rft.au=Rafols%2C+Laia&rft.au=Cooper%2C+Patricia+A&rft.au=Seaton%2C+Colin+C&rft.date=2022-09-16&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1439-4227&rft.eissn=1439-7633&rft.volume=23&rft.issue=18&rft_id=info:doi/10.1002%2Fcbic.202200259&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1439-4227&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1439-4227&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1439-4227&client=summon |